ES2045176T3 - 17-halogeno-metilen-estratrienos. - Google Patents

17-halogeno-metilen-estratrienos.

Info

Publication number
ES2045176T3
ES2045176T3 ES88730274T ES88730274T ES2045176T3 ES 2045176 T3 ES2045176 T3 ES 2045176T3 ES 88730274 T ES88730274 T ES 88730274T ES 88730274 T ES88730274 T ES 88730274T ES 2045176 T3 ES2045176 T3 ES 2045176T3
Authority
ES
Spain
Prior art keywords
halogen
stratrians
methylene
halogenomethylene
oestratrienes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88730274T
Other languages
English (en)
Inventor
Peter Prof Dr Jungblut
Rudolf Prof Dr Wiechert
Rolf Dr Bohlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2045176T3 publication Critical patent/ES2045176T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

17-HALOGENMETILENO-ESTRATRIENOS DE LA FORMULA GENERAL I DONDE R1 ES UN ATOMO DE HIDROGENO, UN GRUPO METILO O ACILO Y R2 ES UN ATOMO HALOGENO. LOS COMPUESTOS MUESTRAN UNA AFINIDAD REDUCIDA CON EL RECEPTOR DE ESTROGENO Y TIENEN UNA MAYOR PERMEABILIDAD DE MEMBRANA CELULAR Y DE VASOS SANGUINEOS Y LINFATICOS COMPARADOS CON ESTRADIOL.
ES88730274T 1987-12-07 1988-12-05 17-halogeno-metilen-estratrienos. Expired - Lifetime ES2045176T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873741800 DE3741800A1 (de) 1987-12-07 1987-12-07 17-halogenmethylen-estratriene

Publications (1)

Publication Number Publication Date
ES2045176T3 true ES2045176T3 (es) 1994-01-16

Family

ID=6342257

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88730274T Expired - Lifetime ES2045176T3 (es) 1987-12-07 1988-12-05 17-halogeno-metilen-estratrienos.

Country Status (9)

Country Link
US (1) US5124321A (es)
EP (1) EP0320438B1 (es)
JP (1) JP2636913B2 (es)
AT (1) ATE80893T1 (es)
AU (1) AU617140B2 (es)
CA (1) CA1324374C (es)
DE (2) DE3741800A1 (es)
ES (1) ES2045176T3 (es)
GR (1) GR3006579T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19509729A1 (de) * 1995-03-13 1996-09-19 Schering Ag 17-Difluormethylen-Estratriene
SE9502921D0 (sv) * 1995-08-23 1995-08-23 Astra Ab New compounds
US5773432A (en) * 1996-10-30 1998-06-30 Schering Aktiengesellschaft Method for lowering plasma levels of lipoprotein(a)
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
CA2571440A1 (en) * 2004-06-29 2006-01-12 Jadolabs Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536703A (en) * 1968-09-11 1970-10-27 Searle & Co N - (3 - alkoxy - 19 - norpregna - 1,3,5(10),17(20) - tetraen - 21 - yl)amines and derivatives thereof
BE787343A (fr) * 1971-08-10 1973-02-09 Hoffmann La Roche Procede pour la preparation de 17-(2-halogenoethylidene)- steroides
YU243975A (en) * 1974-10-14 1982-06-30 Schering Ag Process for obtaining 7-hydroxyestradiols

Also Published As

Publication number Publication date
AU617140B2 (en) 1991-11-21
ATE80893T1 (de) 1992-10-15
CA1324374C (en) 1993-11-16
EP0320438A1 (de) 1989-06-14
AU2665288A (en) 1989-06-08
GR3006579T3 (es) 1993-06-30
EP0320438B1 (de) 1992-09-23
JP2636913B2 (ja) 1997-08-06
DE3741800A1 (de) 1989-06-15
JPH01193295A (ja) 1989-08-03
US5124321A (en) 1992-06-23
DE3874865D1 (de) 1992-10-29

Similar Documents

Publication Publication Date Title
DK142985A (da) Redox-indikatorer
ES453442A1 (es) Procedimiento para preparar una tira de ensayo para sangre oculta en excreta o fluidos del cuerpo.
KR840008317A (ko) 디할로겐화벤젠의 제조방법
DK138982A (da) Fremgangsmaade til fremstilling af bispidinderivater
NO164546C (no) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse.
NO893480L (no) Fremgangsmaate for fremstilling av disubstituerte benzylaminer.
EP0254902A3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
ATE82969T1 (de) 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion 2,4-derivate, deren herstellung und verwendung als heilmittel.
ATE80893T1 (de) 17-halogenmethylen-estratriene.
DE3368468D1 (en) Immersion oil
NO855342L (no) Pyridoyrimidiner og fremgangsmaater for fremstilling derav.
ATE57917T1 (de) Hydroxipyrazol-derivate- verfahren zu ihrer herstellung und ihre verwendung gegen mikroorganismen.
DK691287A (da) 5-floururacilderivater
GR3006948T3 (es)
SE8006953L (sv) Heterocykliska foreningar
ATE12487T1 (de) Chlorierte betaketoester, ihre herstellung und anwendung.
NO156409C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6aaa-methylhydrocortisonderivater.
ES553826A0 (es) Procedimiento para preparar derivados de difluorociclopropano
NO167085C (no) Fremgangsmaate for fremstilling av (1-fenylethyl)-hydrokinon.
ES8303412A1 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
ES538398A0 (es) Procedimiento para la obtencion de tiolan-2,4-dion-3-carboxamidas
NO152045C (no) Fremgangsmaate ved fremstilling av metylforminat og metanol ved omsetning av karbonmonoksyd og hydrogen
DE59106137D1 (de) Oasomycine, Verfahren zu ihrer Herstellung und ihre Verwendung.
ES254785Y (es) Sonda lastrada para alimentacion enteral
ES468360A1 (es) Procedimiento para la preparacion de 2-(2',2',2'-trihalogenetil)-4-halogenciclobutan-1-ona.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 320438

Country of ref document: ES